| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |